Additional experiments to evaluate the effects of the most promising pentacyclic benzimidazole derivatives 6 and 9 on both cancer cell cycle regulation and caspase-3/7 activity yielded results paralleling those of the included reference drug doxorubicin, also confirming a similar mode of action by direct interaction with nucleic acids. This evidence concerns the gene CASP3 and cancer.